Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Alzamend Neuro has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
Alzamend Neuro is headquartered in Newport Beach, United States.
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Alzamend Neuro is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alzamend Neuro — Funding & Investors." VCBacked, February 28, 2025, https://www.vcbacked.co/company/alzamend-neuro. Accessed October 1, 2026.
VCBacked. (2025). Alzamend Neuro — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/alzamend-neuro
{{cite web |title=Alzamend Neuro — Funding & Investors |url=https://www.vcbacked.co/company/alzamend-neuro |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated